Alpine Immune Sciences, Inc.
PD-L2 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF

Last updated:

Abstract:

Provided herein are immunomodulatory proteins comprising variant PD-L2 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.

Status:
Application
Type:

Utility

Filling date:

13 Mar 2018

Issue date:

6 May 2021